ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Programs; Pediatric Brain Tumor Consortium Approved In Concepts By BSA; Concepts For Resource Of Arrayed BAC Clones, Support For Radiation Therapy Trials, OH’d

November 23, 1997

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

VP Joe Biden Will Not Host Komen’s Global Race for the Cure in D.C.

May 11, 2012

Funding Opportunities

April 26, 2002